Data not found

Cost Effectiveness Analysis of Using Multiple Neuromodalities in Treating Severe Traumatic Brain Injury in a Developing Country Like Malaysia

Country : Malaysia
Department : Universiti Sains Malaysia, Malaysia
Project Title : Cost Effectiveness Analysis of Using Multiple Neuromodalities in Treating Severe Traumatic Brain Injury in a Developing Country Like Malaysia
Researcher : Ibrahim, Mohd Ismail , Abdullah, Mazlan , Naing, Lin , Abdullah, Jafri Malin , Idris, Zamzuri , Aljunid, Syed Mohamed
Keyword : R5-920 Medicine (General)
Publisher : Elsevier
Year End : 2007
Identifier : Ibrahim, Mohd Ismail and Abdullah, Mazlan and Naing, Lin and Abdullah, Jafri Malin and Idris, Zamzuri and Aljunid, Syed Mohamed (2007) Cost Effectiveness Analysis of Using Multiple Neuromodalities in Treating Severe Traumatic Brain Injury in a Developing Country Like Malaysia. Asian Journal of Surgery, 30 (4). pp. 261-266. ISSN 1015-9584
Relation : https://doi.org/10.1016/S1015-9584(08)60036-6 , http://eprints.usm.my/38537/
Abstract / Description :

OBJECTIVE: The aim of this study was to determine the cost-effectiveness of using baseline neuromonitoring (BNM) compared with multimodality monitoring (M3) for severe traumatic brain injury (TBI). METHODS: Sixty-two patients with severe TBI underwent a prospective observational study where they were divided into two groups of patients receiving treatment with M3 (32 patients) and BNM (30 patients). The macro and micro costings were performed on each patient. The Barthel Index score after 1 year was used as an outcome measurement tool for both groups. The cost-effectiveness (CE) ratio was calculated using the Poisson regression model. RESULTS: The costs of equipment and consumables between the groups was statistically significant (p < 0.001) after correcting for age and severity of injury. Other cost categories were not significantly different. The crude CE ratios were 168.66 (95% CI: 168.32, 169.03) and 144.16 (95% CI: 143.87, 144.45) for BNM and M3 respectively. The two crude CE ratios were significantly different (p < 0.001). It was calculated by controlling or adjusting age, gender, Glasgow Coma Score, Marshall’s classification at admission and type of injury. The adjusted CE ratios were 171.32 (95% CI: 170.97, 171.68) and 141.50 (95% CI: 141.26, 141.79) for BNM and M3, respectively. The two adjusted CE ratios were significantly different (p < 0.001). CONCLUSION: The application of M3 for severe TBI was more cost-effective than BNM. All calculations were made at 3.8 Malaysian Ringgit (MYR) to the United States dollar (USD). [Asian J Surg 2007;30(4):261–6]

References

Ibrahim, Mohd Ismail and others / et al. (2007). Cost Effectiveness Analysis of Using Multiple Neuromodalities in Treating Severe Traumatic Brain Injury in a Developing Country Like Malaysia.  Malaysia: Universiti Sains Malaysia, Malaysia.
Ibrahim, Mohd Ismail and others / et al. 2007. "Cost Effectiveness Analysis of Using Multiple Neuromodalities in Treating Severe Traumatic Brain Injury in a Developing Country Like Malaysia".  Malaysia: Universiti Sains Malaysia, Malaysia.
Ibrahim, Mohd Ismail and others / et al. "Cost Effectiveness Analysis of Using Multiple Neuromodalities in Treating Severe Traumatic Brain Injury in a Developing Country Like Malaysia."  Malaysia: Universiti Sains Malaysia, Malaysia, 2007. Print.
Ibrahim, Mohd Ismail and others / et al. Cost Effectiveness Analysis of Using Multiple Neuromodalities in Treating Severe Traumatic Brain Injury in a Developing Country Like Malaysia. Malaysia: Universiti Sains Malaysia, Malaysia; 2007.

Export

Share